Primary objective: is evaluation of the investigational product's safety and evaluation of
its effect, in combination with antimicrobial treatment, on urine culture (microbiological
cure, no microbial growth on 24-48 hrs culture). The secondary objective: is evaluation of
the investigational product's effect, in combination with antimicrobial treatment, on disease
related symptoms (Clinical cure, disappearance of symptoms and signs).
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Ahmed Ismail
Collaborators:
Cairo Kidney Center Theodor Bilharz Research Institute